Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
ESMO Open|April 26, 2021
Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index <55%: single-arm phase II studyH Jeong, J Shin, J H Jeong, et al.The Journal of Biological Chemistry|April 17, 1999
Roles of Trp31 in high membrane binding and proinflammatory activity of human group V phospholipase A2S K Han, K P Kim, R Koduri, et al.Leukemia|February 26, 2013
Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cellsJ E Kim, S Yoon, B-R Choi, et al.Fresenius' Journal of Analytical Chemistry|July 14, 2001
Long-term stability of nutrients in a frozen mixed food control materialK M Phillips, A H Simpkins, K R Amanna, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in AsiaD-Y Oh, B Shen, S Satoi, et al.ESMO Open|July 31, 2025
Molecular profile and clinical impact of MDM2 amplification in patients with advanced biliary tract cancerH Yoon, H Jeong, I Park, et al.International Journal of Clinical Pharmacology and Therapeutics|October 21, 2011
Open label, three period, single sequence, study of 5, 25, 50 mg sertraline pharmacokinetics in healthy male Korean volunteersM K Park, K-H Shin, K-P Kim, et al.Nature Immunology|March 29, 2001
Blockade of eosinophil migration and airway hyperresponsiveness by cPLA2-inhibitionS Myou, H Sano, M Fujimura, et al.British Journal of Cancer|April 13, 2013
Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancerJ C Kim, Y J Ha, S A Roh, et al.Oncogene|May 24, 2017
LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesisJ-Y Lee, J-H Park, H-J Choi, et al.Pageof 4